Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Provida OB is a prescription-strength prenatal vitamin and mineral supplement developed and marketed by US Pharmaceutical Corporation. It is specifically formulated to meet the increased nutritional requirements of women during pregnancy and the postpartum period, including lactation. The product typically contains a comprehensive blend of essential micronutrients, including iron (often provided as Sumalate, a ferrous asparto glycinate chelate for improved absorption and gastrointestinal tolerability), folic acid to reduce the risk of neural tube defects, and docosahexaenoic acid (DHA) to support fetal brain and retinal development. The formulation also includes a profile of vitamins A, C, D3, E, and B-complex, along with minerals such as calcium, zinc, and magnesium to support overall maternal health and fetal growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Provida OB.